Avodart (Dutasteride) Cost in Ohio 2026: Prices, Insurance, and Savings

What Dutasteride Actually Costs in Ohio Right Now

The average cash price for a 30-day supply of generic dutasteride 0.5 mg at Ohio retail pharmacies in 2026 is approximately $25. Brand-name Avodart, manufactured by GSK, carries a list price near $290 per month, though almost no one pays that figure out of pocket because generics have been available since 2015.

Pricing varies by pharmacy chain and location within Ohio. CVS, Walgreens, and Kroger pharmacies in Columbus, Cleveland, and Cincinnati typically cluster within a few dollars of the $25 average for generic dutasteride. Independent pharmacies sometimes price slightly higher. Costco and Walmart pharmacies in Ohio tend to sit at or below the state average, occasionally dropping to $15 to $20 for a 90-day supply when purchased with a discount card.

The FDA-approved prescribing information for Avodart specifies a single dosage form: 0.5 mg soft gelatin capsules taken once daily. There is no dose titration, which keeps monthly costs predictable regardless of where you fill the prescription in Ohio.

For patients using dutasteride off-label for androgenetic alopecia, the same 0.5 mg capsule and pricing apply. A phase III randomized trial by Eun et al. (2010, N=153) demonstrated that dutasteride 0.5 mg daily significantly increased hair count compared to placebo over 24 weeks, supporting its use in male pattern hair loss despite lacking an FDA indication for that purpose.

Ohio Medicaid and Dutasteride: What Is Covered

Ohio Medicaid does not cover Avodart or generic dutasteride for BPH or male pattern hair loss. The Ohio Department of Medicaid preferred drug list restricts 5-alpha reductase inhibitors, and dutasteride is not included for these conditions.

This means Ohio Medicaid enrollees who need a 5-alpha reductase inhibitor for BPH will likely be steered toward finasteride, which does appear on the preferred list. Finasteride 5 mg (Proscar) for BPH generally costs $8 to $15 per month as a generic, making it the default first-line option within Ohio's Medicaid formulary.

If a prescriber believes dutasteride is medically necessary over finasteride, a prior authorization request can be submitted. Approval rates for these exceptions are low without documented finasteride failure or intolerance. The Endocrine Society's clinical practice guidelines note that dutasteride inhibits both type I and type II 5-alpha reductase isoenzymes, while finasteride targets only type II, which may justify a switch in patients with inadequate response to finasteride alone.

For hair loss specifically, neither finasteride nor dutasteride carries Ohio Medicaid coverage, because androgenetic alopecia is classified as a cosmetic condition by most state Medicaid programs.

Insurance Coverage for Avodart and Generic Dutasteride in Ohio

Most Ohio commercial insurance plans cover generic dutasteride for BPH with a Tier 2 or Tier 3 copay, typically ranging from $10 to $35 per month. Brand-name Avodart, when covered at all, usually sits on Tier 3 or a specialty tier with copays of $50 to $100 or higher.

Plans offered through the Ohio Health Insurance Marketplace (ACA exchange) generally follow a similar pattern: generic dutasteride is covered, brand Avodart is not preferred. UnitedHealthcare, Anthem Blue Cross Blue Shield, and Medical Mutual of Ohio, the three largest insurers in the state, all include generic dutasteride on their formularies for BPH as of 2026.

Off-label coverage for hair loss is a different situation entirely. Insurers in Ohio almost universally exclude dutasteride for androgenetic alopecia. Even when the same 0.5 mg capsule is prescribed, the diagnosis code determines coverage. A BPH diagnosis (ICD-10 N40.1) will process. An androgenetic alopecia diagnosis (L64.9) will not.

According to the American Academy of Dermatology, dutasteride's efficacy for hair loss is supported by clinical evidence, but insurance formularies have not followed suit. Patients using dutasteride for hair loss in Ohio should expect to pay cash.

Compounded Dutasteride in Ohio: Legality and Cost

Compounded dutasteride from a licensed 503A pharmacy is legal in Ohio. A 503A pharmacy operates under Section 503A of the Federal Food, Drug, and Cosmetic Act, compounding medications based on individual patient prescriptions.

Ohio-licensed 503A compounding pharmacies can prepare dutasteride capsules or topical formulations at approximately $40 per month. This is higher than generic retail pricing but becomes relevant for patients who need a non-standard dosage, a topical formulation for scalp application, or a combination product (such as dutasteride combined with minoxidil in a single topical solution).

The Ohio Board of Pharmacy regulates these compounding pharmacies. To legally dispense compounded dutasteride, a pharmacy must hold a valid Ohio Terminal Distributor of Dangerous Drugs license and comply with USP compounding standards. Patients should verify that any compounding pharmacy they use holds current Ohio licensure.

Ohio Dutasteride Decision Framework:

| Scenario | Best Option | Estimated Monthly Cost | |---|---|---| | BPH with commercial insurance | Generic dutasteride at retail pharmacy | $10 to $35 copay | | BPH without insurance | Generic dutasteride + discount card | $15 to $25 | | Hair loss, standard capsule | Generic dutasteride cash-pay | $20 to $30 | | Hair loss, topical formulation | 503A compounded dutasteride | $35 to $50 | | Ohio Medicaid enrollee, BPH | Finasteride (preferred) or PA for dutasteride | $0 to $3 | | Combination topical (dutasteride + minoxidil) | 503A compounded | $45 to $65 |

This framework reflects 2026 Ohio pricing. Cash prices fluctuate quarterly, so confirm with your pharmacy before filling.

How to Get the Cheapest Dutasteride in Ohio

The lowest-cost path for most Ohio patients is generic dutasteride 0.5 mg at a retail pharmacy using a discount program. GoodRx, RxSaver, and SingleCare all offer coupons that bring the price to $10 to $25 at major Ohio chains. These programs work regardless of insurance status.

Walmart's $4 generic list does not include dutasteride, but Costco pharmacy (no membership required for pharmacy use in Ohio) often prices generic dutasteride at $12 to $18 for a 30-day supply. Mark Cuban's Cost Plus Drugs prices generic dutasteride at $5.40 for a 30-day supply as of May 2026, plus shipping. For patients comfortable with mail-order, this represents the lowest per-unit cost available to Ohio residents.

GSK discontinued its branded Avodart savings card program in 2023, but some generic manufacturers offer modest rebates. Mylan and Cipla, two of the largest generic dutasteride manufacturers, occasionally provide coupons through pharmacy benefit platforms.

A 90-day fill almost always reduces cost per capsule compared to 30-day fills. Patients without insurance should ask their Ohio pharmacy about 90-day cash pricing, which typically runs $50 to $65, saving 15% to 30% compared to three separate monthly fills.

The FDA Orange Book lists multiple approved generic dutasteride manufacturers, ensuring continued price competition in Ohio's pharmacy market.

Telehealth Prescribing of Dutasteride in Ohio

Ohio permits telehealth prescribing of dutasteride. The Ohio State Medical Board allows physicians and advanced practice providers to prescribe medications, including dutasteride, following a synchronous telehealth visit conducted via audio-video communication.

This means Ohio residents in rural areas without a nearby urologist or dermatologist can obtain a dutasteride prescription through a licensed telehealth platform. Several direct-to-consumer telehealth companies operating in Ohio prescribe dutasteride for both BPH and hair loss, typically bundling the consultation fee ($20 to $75) with optional medication delivery.

HealthRX offers telehealth consultations for dutasteride with board-certified providers licensed in Ohio. Prescriptions are sent to the patient's preferred Ohio pharmacy or can be filled through a partner pharmacy with home delivery.

Ohio's telehealth parity law (ORC 3902.30) requires commercial insurers to cover telehealth visits at the same rate as in-person visits, though the medication itself still follows standard formulary rules. The telehealth visit copay is often $0 to $25 for insured patients.

A key clinical consideration: the prescribing information warns that dutasteride is contraindicated in women who are or may become pregnant due to teratogenic risk. Telehealth providers in Ohio must confirm patient sex and pregnancy status before prescribing.

Dutasteride vs. Finasteride: Ohio Cost Comparison

Finasteride is the only other FDA-approved 5-alpha reductase inhibitor, and in Ohio it costs less. Generic finasteride 5 mg (for BPH) runs $4 to $10 per month; generic finasteride 1 mg (for hair loss, branded as Propecia) costs $8 to $15 per month.

Generic dutasteride at $20 to $25 per month is roughly two to three times the price of finasteride in Ohio. The clinical question is whether that premium buys meaningful additional benefit.

A randomized, double-blind trial published in the Journal of the American Academy of Dermatology (Eun et al., 2010) found dutasteride 0.5 mg superior to finasteride 1 mg for increasing hair count in men with androgenetic alopecia at 24 weeks. Target area hair counts increased by 12.2% with dutasteride versus 4.7% with finasteride (P<0.05).

For BPH, the CombAT trial (N=4,844) demonstrated that dutasteride combined with tamsulosin reduced the relative risk of BPH clinical progression by 41% compared to tamsulosin alone over 4 years. The American Urological Association guidelines reference this trial when recommending combination therapy for men with large prostates (volume >30 mL).

Ohio patients deciding between the two drugs should weigh the $10 to $15 monthly premium for dutasteride against these clinical differences. For men who have tried finasteride without adequate response, the incremental cost of dutasteride is straightforward to justify.

Side Effects and Monitoring Considerations

Dutasteride's side effect profile is well-characterized. The most commonly reported adverse effects in clinical trials include decreased libido (1% to 5%), erectile dysfunction (3% to 7%), and ejaculation disorders (1% to 3%), according to the FDA label.

One Ohio-specific practical note: dutasteride lowers PSA (prostate-specific antigen) levels by approximately 50% within 3 to 6 months of use. Ohio physicians monitoring PSA for prostate cancer screening must double the measured PSA value in patients taking dutasteride to estimate the true level. The American Cancer Society and AUA guidelines both emphasize this adjustment.

Dutasteride has a long half-life of approximately 5 weeks at steady state, far longer than finasteride's 6 to 8 hours. This means side effects, if they occur, may persist for weeks to months after discontinuation. Ohio patients starting dutasteride should understand this pharmacokinetic reality before beginning therapy.

Dr. Ken Washenik, past president of the American Hair Loss Association, has stated: "Dutasteride offers a more complete blockade of DHT production than finasteride, which can translate into greater clinical effect for some patients, but the longer half-life demands careful patient counseling before initiation."

Blood donation restrictions also apply. The FDA recommends waiting at least 6 months after the last dose of dutasteride before donating blood, to prevent exposure of a pregnant transfusion recipient to the drug. Ohio blood banks, including the American Red Cross locations in Columbus, Cleveland, and Cincinnati, enforce this deferral.

What to Ask Your Ohio Provider Before Starting Dutasteride

Patients considering dutasteride should discuss three things with their prescriber. First, whether their insurance formulary covers generic dutasteride or requires a prior authorization. Second, whether a baseline PSA should be drawn before starting therapy, so future PSA values can be interpreted correctly. Third, whether a 90-day fill makes financial sense based on their copay structure or cash-pay situation.

For men using dutasteride off-label for hair loss, a digital photograph of the scalp at baseline helps track response over the 6 to 12 months typically needed to assess efficacy. The Eun et al. trial measured significant improvement at 24 weeks, but many clinicians recommend a full 12-month trial before concluding the drug has failed.